Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DT Midstream, Inc.DTM · Entity 3411 | Director | May 06, 2022 | May 10, 2022 |
| Fortive CorpFTV · Entity 3303 | Director | September 25, 2026 | September 28, 2026 |
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director | July 22, 2026 | July 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DT Midstream, Inc.
Report date May 06, 2022 · Filed May 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,795 |
Reported balance
After 2022-05-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-06 · Grant · Acquired 1,795 · Balance 1,795 F1: Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. F2: This restricted stock unit will vest on May 5, 2023, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.
F2: This restricted stock unit will vest on May 5, 2023, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
Fortive Corp
Report date September 25, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,766.252 |
Reported balance
After 2026-09-25 transaction · row 1
1 source rowRow 1 · 2026-09-25 · Other · Acquired 5.366 · Balance 25,766.252 F1: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm.
QUEST DIAGNOSTICS INC
Report date July 22, 2026 · Filed July 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,323 |
Reported balance
After 2026-07-22 transaction · row 1
1 source rowRow 1 · 2026-07-22 · Other · Acquired 6 · Balance 10,323 F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2026 Filed Sep 28, 2026 23:08 UTC | Fortive Corp FTV · Entity 3303 | OtherCommon Stock | 5.366 | $55.92 | $300.04 |
DisclosureSEC source: 0001805909-26-000011 · wk-form4_1790636896.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,766.252 F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm. Read SEC document |
| July 22, 2026 Filed Jul 27, 2026 20:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 6 | $206.81 | $1,240.88 |
DisclosureSEC source: 0001022079-26-000080 · wk-form4_1785184383.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,323 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC | Fortive Corp FTV · Entity 3303 | OtherCommon Stock | 4.136 | $62.12 | $256.93 |
DisclosureSEC source: 0001659166-26-000026 · wk-form4_1783457240.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,760.886 F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:49 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,925 | $59.78 | $115,076.50 |
DisclosureSEC source: 0001805909-26-000009 · wk-form4_1781210986.xml · nonDerivative · entry 2 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,756.75 F2 · shares: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $59.78, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the third year following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:49 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001805909-26-000009 · wk-form4_1781210986.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,831.75 F1 · shares: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, but, based on the election of the Reporting Person, the underlying shares will not be issued until the earlier of the Reporting Person's death or the third year following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:54 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001805909-26-000007 · wk-form4_1779396839.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,317 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 20, 2026 Filed Apr 24, 2026 22:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 6 | $194.70 | $1,168.19 |
DisclosureSEC source: 0001022079-26-000046 · wk-form4_1777069413.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,063 F1 · security: Represents an award of restricted share units. F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:33 UTC | Fortive Corp FTV · Entity 3303 | OtherCommon Stock | 4.67 | $54.98 | $256.76 |
DisclosureSEC source: 0001805909-26-000004 · wk-form4_1774903300.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,481.75 F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm. Read SEC document |
| January 28, 2026 Filed Feb 20, 2026 22:08 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 7 | $183.51 | $1,284.57 |
DisclosureSEC source: 0001022079-26-000011 · wk-form4_1771625304.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,057 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 23:04 UTC | Fortive Corp FTV · Entity 3303 | OtherCommon Stock | 4.61 | $55.69 | $256.73 |
DisclosureSEC source: 0001805909-25-000003 · wk-form4_1767135891.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,477.08 F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 157 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000206 · wk-form4_1759523536.xml · derivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 678.777 Underlying: Common Stock · 157 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · derivative.underlying_shares: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| July 21, 2025 Filed Jul 25, 2025 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 7 | $167.51 | $1,172.54 |
DisclosureSEC source: 0001022079-25-000186 · wk-form4_1753475235.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,044 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000165 · wk-form4_1751487991.xml · derivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520.854 Underlying: Common Stock · 160 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · derivative.underlying_shares: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:01 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,140 | $0.00 Strike: $70.26 | $0.00 |
DisclosureSEC source: 0001659166-25-000084 · wk-form4_1749081677.xml · derivative · entry 3 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,140 Underlying: Common Stock · 2,140 shares Expires 2035-06-02 Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:01 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,625 | $70.87 | $115,163.75 |
DisclosureSEC source: 0001659166-25-000084 · wk-form4_1749081677.xml · nonDerivative · entry 2 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,119.884 F2 · shares: On June 2, 2025, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $70.87, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of and immediately prior to the Issuer's 2026 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the three-year anniversary of the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:01 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-25-000084 · wk-form4_1749081677.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,494.884 F1 · shares: On June 2, 2025, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of and immediately prior to the Issuer's 2026 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the third anniversary of the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000144 · wk-form4_1747686084.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,037 F1 · security: Represents an award of restricted stock units. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 169 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000105 · wk-form4_1743712825.xml · derivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359.911 Underlying: Common Stock · 169 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| March 27, 2025 Filed Apr 1, 2025 00:10 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2.451 | $74.82 | $183.39 |
DisclosureSEC source: 0001659166-25-000063 · wk-form4_1743466224.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,374.884 F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:48 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000003 · wk-form4_1736200076.xml · derivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190 Underlying: Common Stock · 190 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. Read SEC document |
| December 26, 2024 Filed Dec 30, 2024 22:07 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2.433 | $75.30 | $183.20 |
DisclosureSEC source: 0001659166-24-000171 · wk-form4_1735596433.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,372.433 F1 · shares: Reflects shares acquired through an automatic dividend reinvestment service offered to the Reporting Person by a third party brokerage firm. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:11 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 1,990 | $0.00 Strike: $72.95 | $0.00 |
DisclosureSEC source: 0001659166-24-000127 · wk-form4_1717632678.xml · derivative · entry 3 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,990 Underlying: Common Stock · 1,990 shares Expires 2034-06-03 Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:11 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,515 | $76.14 | $115,352.10 |
DisclosureSEC source: 0001659166-24-000127 · wk-form4_1717632678.xml · nonDerivative · entry 2 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,370 F2 · shares: On June 3, 2024, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $76.14, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:11 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-24-000127 · wk-form4_1717632678.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,855 F1 · shares: On June 3, 2024, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| May 16, 2024 Filed May 20, 2024 23:17 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-24-000119 · wk-form4_1716247063.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,709 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:43 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,310 | $0.00 Strike: $67.23 | $0.00 |
DisclosureSEC source: 0001659166-23-000158 · wk-form4_1686260576.xml · derivative · entry 3 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,310 Underlying: Common Stock · 2,310 shares Expires 2033-06-06 Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:43 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,755 | $65.60 | $115,128.00 |
DisclosureSEC source: 0001659166-23-000158 · wk-form4_1686260576.xml · nonDerivative · entry 2 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,885 F2 · shares: On June 6, 2023, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $65.60, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2024 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:43 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-23-000158 · wk-form4_1686260576.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,130 F1 · shares: On June 6, 2023, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2024 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:21 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-23-000115 · wk-form4_1684534851.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,092 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:25 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 4,570 | $0.00 Strike: $63.00 | $0.00 |
DisclosureSEC source: 0001659166-22-000117 · wf-form4_165471990838406.xml · derivative · entry 3 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,570 Underlying: Common Stock · 4,570 shares Expires 2032-06-06 Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:25 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,930 | $59.74 | $115,298.20 |
DisclosureSEC source: 0001659166-22-000117 · wf-form4_165471990838406.xml · nonDerivative · entry 2 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,840 F2 · shares: On June 6, 2022, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $59.74, pursuant to deferral election made by the Reporting Person of $115,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2023 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:25 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-22-000117 · wf-form4_165471990838406.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,910 F1 · shares: On June 6, 2022, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2023 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000089 · wf-form4_165307839400151.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,633 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 60 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:54 UTC | DT Midstream, Inc. DTM · Entity 3411 | GrantRestricted Stock Units · Derivative | 1,795 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-22-000535 · ownership.xml · derivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,795 Underlying: Common Stock · 1,795 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. F2 · derivative.exercise_date: This restricted stock unit will vest on May 5, 2023, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. F2 · derivative.expiration_date: This restricted stock unit will vest on May 5, 2023, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 24, 2022 Filed Jan 26, 2022 21:34 UTC | Fortive Corp FTV · Entity 3303 | GrantEmployee Stock Option (Right to Buy) · Derivative | 1,860 | $71.96 Strike: $71.96 | $133,845.60 |
DisclosureSEC source: 0001659166-22-000006 · wf-form4_164323285688097.xml · derivative · entry 3 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,860 Underlying: Common Stock · 1,860 shares Expires 2032-01-24 Read SEC document |
| January 24, 2022 Filed Jan 26, 2022 21:34 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 785 | $73.43 | $57,642.55 |
DisclosureSEC source: 0001659166-22-000006 · wf-form4_164323285688097.xml · nonDerivative · entry 2 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F3 · shares: On January 24, 2022, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $73.43, pursuant to deferral election made by the Reporting Person of $57,500 in prorated annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2022 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| January 24, 2022 Filed Jan 26, 2022 21:34 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 615 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-22-000006 · wf-form4_164323285688097.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 615 F1 · shares: On January 24, 2022, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as prorated portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2022 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. F2 · price: RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 21:30 UTC | DT Midstream, Inc. DTM · Entity 3411 | GrantRestricted Stock Units · Derivative | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-21-000854 · ownership.xml · derivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,417 Underlying: Common Stock · 2,417 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: This restricted stock unit will vest 25% on August 2, 2023, 25% on August 2, 2024 and 50% on August 2, 2025, subject to the Reporting Persons' continued service with the Issuer through the applicable vesting date. F2 · derivative.expiration_date: This restricted stock unit will vest 25% on August 2, 2023, 25% on August 2, 2024 and 50% on August 2, 2025, subject to the Reporting Persons' continued service with the Issuer through the applicable vesting date. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000093 · wf-form4_162197542300450.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,281 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000129 · wf-form4_159009393260707.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,882 F1 · security: Represents an award of restricted share units. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 20:55 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 351 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000087 · wf-form4_158439209905299.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351 F1 · security: Represents an award of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.